CEL SCI CORP
Datakwaliteit: 83%
CVM
NYSE
Manufacturing
Chemicals
€ 4,27
▼
€ 0,12
(-2,73%)
Marktkapitalisatie: 36,11 M
Prijs
€ 4,27
Marktkapitalisatie
36,11 M
Dagbereik
€ 3,92 — € 4,54
52-Weeksbereik
€ 1,98 — € 13,48
Volume
43.834
Openen € 4,36
50D / 200D Gem.
€ 4,37
2,22% below
50D / 200D Gem.
€ 6,43
33,58% below
Quick Summary
Belangrijkste Punten
Negative free cash flow of -17,01 M
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-262,14%
Onder sectorgemiddelde (-53,41%)
ROIC-112,94%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
N/A
Current Ratio1,39
Interest Coverage-25,67
Waardering
PE (TTM)
-1,52
Onder sectorgemiddelde (-1,48)
P/B Ratio3,24
EV/EBITDAN/A
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -1,5 | -1,5 |
| P/B | 3,2 | 1,6 |
| ROE % | -262,1 | -53,4 |
| Net Margin % | — | -41,5 |
| Rev Growth 5Y % | — | 1,8 |
| D/E | — | 0,3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -23,81 M |
| ROE | -262,14% | ROA | -110,14% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -17,01 M |
| ROIC | -112,94% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 1,39 |
| Interest Coverage | -25,67 | Asset Turnover | N/A |
| Working Capital | 1,99 M | Tangible Book Value | 11,04 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -1,52 | Forward P/E | N/A |
| P/B Ratio | 3,24 | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -47,09% | ||
| Market Cap | 36,11 M | Enterprise Value | 36,11 M |
| Per Share | |||
| EPS (Diluted TTM) | -6,84 | Revenue / Share | N/A |
| FCF / Share | -2,01 | OCF / Share | -2,01 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 71,44% |
| SBC-Adj. FCF | -18,92 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | -25,41 M | -27,58 M | -32,19 M | -36,70 M | -36,36 M |
| EPS (Diluted) | -6,27 | -0,51 | — | -0,87 | -0,93 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -24,81 M | -26,35 M | -31,48 M | -36,06 M | -36,19 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 15,89 M | 18,16 M | 22,47 M | 25,36 M | 23,11 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | 2,06 M | 2,14 M | 2,11 M | 1,98 M | 447.000,0 |
| Interest Expense | 649.000,0 | 745.673,0 | 675.416,0 | -1,08 M | -1,15 M |
| Income Tax | — | — | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 28,16 M | 26,99 M | 30,53 M | 50,52 M | 75,87 M |
| Total Liabilities | 12,20 M | 14,12 M | 17,31 M | 18,36 M | 19,34 M |
| Shareholders' Equity | 15,96 M | 12,87 M | 13,21 M | 32,16 M | 56,53 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | — | — | — | 22,67 M | 36,06 M |
| Current Assets | 11,60 M | 6,06 M | 6,92 M | 25,44 M | 45,27 M |
| Current Liabilities | 5,13 M | 4,62 M | 5,59 M | 4,66 M | 3,94 M |
{"event":"ticker_viewed","properties":{"ticker":"CVM","listing_kind":"stock","pathname":"/stocks/cvm","exchange":"NYSE","country":"US"}}